![Paul-Henri Lambert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul-Henri Lambert
Directeur/Membre du Conseil chez Hookipa Biotech AG
Profil
Paul-Henri Lambert is currently the Director of the International Advanced Vaccinology Course at the University of Geneva.
He also holds the position of Director of the International Advanced Vaccinology Course at Fondation Mérieux.
Additionally, he serves as a Member of the Supervisory Board at Hookipa Biotech AG.
Previously, he worked as the Director at HOOKIPA Pharma, Inc. from 2011 to 2019.
Postes actifs de Paul-Henri Lambert
Sociétés | Poste | Début |
---|---|---|
Hookipa Biotech AG
![]() Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Directeur/Membre du Conseil | - |
Fondation Mérieux | Corporate Officer/Principal | 14/11/2013 |
University of Geneva | Corporate Officer/Principal | - |
Anciens postes connus de Paul-Henri Lambert
Sociétés | Poste | Fin |
---|---|---|
HOOKIPA PHARMA INC. | Directeur/Membre du Conseil | 25/04/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
HOOKIPA PHARMA INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Hookipa Biotech AG
![]() Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Health Technology |
Fondation Mérieux | Miscellaneous |